Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Essapen, Sharadah"'
Autor:
Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK. Electronic address: tim.iveson@uhs.nhs.uk., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Saunders MP; The Christie Hospital, Manchester, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Melbourne, VIC, Australia., Glimelius B; IGP, University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Scudder C; OCTO, University of Oxford, Department of Oncology, Oxford, UK., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Briggs A; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Center for Health and Policy Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrookes Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospital NHS Trust, Truro, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Harrison M; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Bridgewater J; UCL Cancer Institute, University College London, London UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden Hospital, London, UK., Hickish T; Poole Hospital, Bournemouth University, Bournemouth, UK., Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan HS; Hammersmith Hospital, Imperial College London, London, UK., Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Apr; Vol. 19 (4), pp. 562-578.
Autor:
Gollins S; Department of Oncology, North Wales Cancer Treatment Centre, Bodelwyddan, Denbighshire LL18 5UJ, UK., West N; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Sebag-Montefiore D; St James' Institute of Oncology, University of Leeds, Leeds LS9 7TF, UK., Myint AS; Clatterbridge Cancer Centre, Clatterbridge Road, Wirral CH63 4JY, UK., Saunders M; The Christie NHS Foundation Trust, Withington, Manchester M20 4BX, UK., Susnerwala S; Royal Preston Hospital, Fulwood, Preston PR2 9HT, UK., Quirke P; Pathology and Tumour Biology, Level 4 Wellcome Trust Brenner Building, St James University Hospital, Beckett Street, Leeds LS9 7TF, UK., Essapen S; St Luke's Cancer Centre, Egerton Road, Guildford GU2 7XX, UK., Samuel L; Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK., Sizer B; Colchester General Hospital, Turner Road, Colchester CO4 5JL, UK., Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK., Southward K; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Hemmings G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Tinkler-Hundal E; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Taylor M; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Bottomley D; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Chambers P; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK., Lawrie E; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK., Lopes A; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK., Beare S; Cancer Research UK & UCL Cancer Trials Centre, University College London, 90 Tottenham Court Road, London W1T 4TJ, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Oct 24; Vol. 117 (9), pp. 1286-1294. Date of Electronic Publication: 2017 Aug 31.
Autor:
Gollins S; Department of Clinical Oncology, North Wales Cancer Treatment Centre, Rhyl, LL18 5UJ United Kingdom. simon.gollins@wales.nhs.uk, Sun Myint A, Haylock B, Wise M, Saunders M, Neupane R, Essapen S, Samuel L, Dougal M, Lloyd A, Morris J, Topham C, Susnerwala S
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2011 Mar 10; Vol. 29 (8), pp. 1042-9. Date of Electronic Publication: 2011 Jan 24.